About this archived opportunity

Cooperative agreements under the ADPI funding Notice of Funding Opportunity (NOFO), are intended to support and promote the development and expansion of dementia-capable home and community-based service (HCBS) systems in States and Communities. There are two application options contained in this single NOFO: Grants to States (Option A) and Grants to Communities (Option B). No entity is eligible to apply for both State and Community options and no entity is eligible to hold more than one ADPI grant at a time. The dementia-capable systems resulting from program activities under either option are expected to provide quality, person-centered services and supports that help individuals living with dementia and their caregiver remain independent and safe in their communities.OPTION A: Grants to StatesApplicants for Option A (36 month cooperative agreements) are the governmental entities within states and territories designated as the state agency for dementia-capability and that have working relationships with their state agencies that enable creating and sustaining a dementia- capable HCBS System. Option A has two required objectives, the first of which is the creation, expansion and sustainability of a dementia-capable state HCBS system that includes Single Entry Point/No Wrong Door (SEP/NWD) access for people with dementia and their family caregivers. The second objective is to ensure access to a comprehensive, sustainable set of quality state HCBS that are dementia-capable and provide innovative services to the population with dementia and their caregivers.States and territories eligible for Option A are those that do not have active ACL ADPI State dementia-capability grants. All states without active grants are eligible to apply, however those states that have not benefited from ADSSP grants since before 2014 will be given priority consideration in the post-review decision-making process.OPTION B: Grants to CommunitiesCooperative agreements under Option B (36 month c

Related opportunities

• Addressing Dementia in Tribal and Urban Indian Communities: CAReS ProgramIndian Health Service·Closes in 24 days·Up to $750K
• DoW Alzheimer’s Transforming Diagnosis AwardDefense Health Agency Contracting Activity - DHACA·Closes in 44 days
• Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)National Institutes of Health·Closes Nov 2026
• DoW Alzheimer’s Transforming Care AwardDefense Health Agency Contracting Activity - DHACA·Closes in 44 days
• Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)National Institutes of Health·Closes Nov 2027·Up to $1.5M
• Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)National Institutes of Health·Closes in 45 days